Doctors across Europe treat portal hypertension in children very differently, according to a 2026 survey by pediatric specialists. While most doctors agree on using a throat camera to prevent and treat bleeding, they disagree significantly on which medicines to use, how to measure liver scarring, and when to perform certain procedures. This variation suggests that children’s treatment depends partly on which hospital they visit rather than on established best practices, highlighting the urgent need for standardized, research-based guidelines.
According to Gram Research analysis, doctors around the world don’t always agree on how to treat portal hypertension, a serious liver condition in children. Portal hypertension happens when blood pressure gets too high in the veins leading to the liver. A new survey of pediatric doctors found that while most agree on basic definitions and use a camera to look down the throat, they disagree on many treatment choices, including which medicines to use and when to do special imaging tests. The research shows we need better guidelines so all children get the same high-quality care no matter where they live.
Key Statistics
A 2026 questionnaire-based study of pediatric gastroenterologists found that while most clinicians agree on key definitions of portal hypertension and regularly use esophagogastroduodenoscopy for preventing bleeding, notable differences remain in the application of non-selective beta-blockers across medical centers.
According to a 2026 survey by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, liver and spleen stiffness measurements are increasingly used to assess portal hypertension in children, but no standardized pediatric thresholds currently exist, leading to inconsistent interpretation of results.
A 2026 research review found that anticoagulation protocols following interventional procedures for portal hypertension are applied inconsistently across pediatric medical centers, indicating a lack of standardized guidelines for blood-thinning medication use after treatment.
The Quick Take
- What they studied: How different children’s hospitals and doctors treat portal hypertension, a condition where blood pressure builds up in the liver’s blood vessels.
- Who participated: Pediatric gastroenterologists (doctors who specialize in children’s digestive and liver health) from multiple medical centers across Europe who responded to a questionnaire about their treatment practices.
- Key finding: Doctors agree on some basics like using a camera to look at the esophagus and stomach, but they disagree significantly on which medicines to use, how to measure liver stiffness, and when to do certain procedures.
- What it means for you: If your child has portal hypertension, the treatment they receive might depend more on which hospital they go to than on what research says works best. This highlights the need for clearer, standardized treatment guidelines.
The Research Details
Researchers from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition created a questionnaire to ask doctors about how they manage portal hypertension in children. This follow-up survey built on earlier research and focused on treatment areas that hadn’t been fully explored before. Doctors from different medical centers answered questions about their practices, allowing researchers to identify where treatments are similar and where they differ significantly.
This type of study is called a survey or questionnaire-based study. It’s useful for understanding real-world practices across many hospitals and doctors. However, it shows what doctors currently do, not necessarily what works best. The researchers weren’t testing a new treatment or comparing two groups of patients. Instead, they were gathering information about current practices to identify gaps and inconsistencies.
Understanding how doctors currently treat portal hypertension is important because it reveals whether children are getting consistent, evidence-based care. When treatment approaches vary widely without clear scientific reasons, some children may receive less effective care than others. This type of survey helps identify areas where standardized guidelines are needed most urgently.
This study provides valuable information about current medical practices but has limitations. The researchers didn’t verify whether the doctors’ reported practices actually match what they do in real situations. The study doesn’t tell us which treatment approaches work best, only which ones doctors currently use. The sample size of respondents wasn’t specified, which makes it harder to know how representative these findings are of all pediatric doctors treating this condition.
What the Results Show
The survey revealed that most pediatric doctors agree on the basic definition of portal hypertension and regularly use a procedure called esophagogastroduodenoscopy (a camera that looks down the throat into the stomach and upper intestines) for both preventing bleeding and treating it after it occurs.
However, significant disagreement exists about using non-selective beta-blockers, which are medicines that help reduce blood pressure in the liver’s vessels. Some doctors use these medicines regularly while others use them less frequently, suggesting different approaches to preventing dangerous bleeding.
Doctors also vary in how they use liver and spleen stiffness measurements, which are ultrasound-based tests that show how hard or scarred the liver has become. While more doctors are using these non-invasive tests, there are no agreed-upon normal values for children, making it hard to interpret results consistently.
Additional disagreements exist about managing portal vein thrombosis (blood clots in the liver’s main vein), deciding when to place special shunts (surgical bypasses), and using interventional radiology procedures (minimally invasive techniques guided by imaging). After these procedures, doctors also apply blood-thinning medications inconsistently.
The research identified that anticoagulation protocols, which are the rules doctors follow for giving blood-thinning medications after procedures, are applied very differently across centers. This variation suggests that some children may receive different levels of blood clot prevention depending on where they’re treated. The lack of standardized thresholds for liver stiffness measurements means doctors may interpret the same test results differently, potentially leading to different treatment decisions for similar patients.
This follow-up survey builds on earlier research by the same group that first documented variations in portal hypertension care. The new findings confirm that inconsistencies persist and reveal additional areas of disagreement that weren’t explored in the initial survey. The research aligns with a broader pattern in pediatric medicine where treatment approaches often vary more than evidence would suggest they should.
The study doesn’t specify how many doctors responded to the questionnaire, making it unclear how representative the findings are. The research shows what doctors report doing, not necessarily what they actually do in practice. The survey doesn’t evaluate which treatment approaches produce the best outcomes for children, only documents current practices. Without outcome data, we can’t determine whether variations in care lead to different results for patients. The study focuses on European practices and may not reflect how doctors in other regions treat this condition.
The Bottom Line
If your child has portal hypertension, ask your doctor which treatment approach they recommend and why. Request information about whether your hospital follows any specific guidelines or protocols. Consider seeking a second opinion from a specialist at a major medical center, particularly if your child needs complex procedures. The current evidence suggests that standardized care based on research is needed, but such guidelines don’t yet exist for all aspects of treatment.
Parents and caregivers of children with portal hypertension should care about these findings because they show that treatment quality may vary depending on location. Pediatric doctors and hospital administrators should care because this research highlights the need for better guidelines. Healthcare policymakers should use this information to prioritize funding for research that establishes best practices.
Changes in treatment approaches typically take several years to implement after new guidelines are established. Prospective clinical trials to establish better guidelines would likely take 3 to 5 years to complete. Once guidelines are published, adoption across hospitals typically takes another 1 to 3 years.
Frequently Asked Questions
What is portal hypertension in children and why does it matter?
Portal hypertension is high blood pressure in the veins that carry blood to the liver. It matters because it can cause dangerous bleeding in the esophagus and stomach. A 2026 survey shows treatment varies widely across hospitals, meaning some children may receive less consistent care than others.
Do all doctors treat children’s portal hypertension the same way?
No. A 2026 survey found that while doctors agree on basic definitions and using throat cameras to check for bleeding, they disagree significantly on which medicines to use, how to measure liver scarring, and when to perform procedures like shunt placement.
What are non-selective beta-blockers and why do doctors disagree about using them?
Non-selective beta-blockers are medicines that reduce blood pressure in the liver’s blood vessels to prevent dangerous bleeding. Doctors disagree about how often to use them because current guidelines aren’t standardized, so some use them regularly while others use them less frequently.
What is liver stiffness measurement and how is it used?
Liver stiffness measurement is an ultrasound test that shows how scarred or hard the liver has become. More doctors are using it to assess portal hypertension, but because there are no agreed-upon normal values for children, doctors interpret results differently.
When will there be better guidelines for treating children with portal hypertension?
The 2026 survey recommends conducting prospective clinical trials to establish standardized guidelines. These trials typically take 3 to 5 years to complete, with adoption across hospitals taking another 1 to 3 years after publication.
Want to Apply This Research?
- Track your child’s portal hypertension appointments, procedures, and medications in a health app. Record the specific treatments recommended, dates of esophagogastroduodenoscopy procedures, any liver stiffness measurements, and blood pressure readings. This creates a clear record to share with doctors and helps identify patterns in your child’s care.
- Use the app to maintain a detailed medication log for any beta-blockers or blood-thinning medications prescribed. Set reminders for regular follow-up appointments and imaging tests. Document any bleeding episodes or concerning symptoms to discuss with your doctor.
- Establish a long-term tracking system that records all procedures, test results, and medication changes over months and years. This helps you and your medical team monitor disease progression and treatment effectiveness. Share this information with any new doctors your child sees to ensure continuity of care.
This article summarizes research about current medical practices for portal hypertension in children. It is not medical advice. Portal hypertension is a serious condition requiring specialized medical care. If your child has been diagnosed with portal hypertension or shows symptoms like abdominal swelling, vomiting blood, or black stools, consult a pediatric gastroenterologist or hepatologist immediately. Treatment decisions should be made in consultation with your child’s medical team based on their individual condition, not on general information from this article. The variations in care described here highlight why seeking care from experienced specialists at major medical centers is important.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.